Dynamic alterations of bone marrow cytokine landscape of myelodysplastic syndromes patients treated with 5-azacytidine

Myelodysplastic syndromes (MDS) represent a heterogeneous group of clonal stem cell disorders characterized by ineffective hematopoiesis frequently progressing into acute myeloid leukemia (AML), with emerging evidence implicating aberrant bone marrow (BM) microenvironment and inflammation-related ch...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncoimmunology
Autores principales: Moudra, Alena, Hubackova, Sona, Machalova, Veronika, Vancurova, Marketa, Bartek, Jiri, Reinis, Milan, Hodny, Zdenek, Jonasova, Anna
Formato: Artigo
Lenguaje:Inglês
Publicado: Taylor & Francis 2016
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5087287/
https://ncbi.nlm.nih.gov/pubmed/27853634
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1183860
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares